{"id":"phenobarbitone","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Achalasia of esophagus","Acute erosive gastritis","Acute exacerbation of asthma","Acute hepatitis","Acute nephropathy","Acute tuberculosis","Agoraphobia","Agranulocytosis","Alcohol intoxication","Alcoholism","Anemia","Anemia due to enzyme deficiency","Angina pectoris","Angle-closure glaucoma","Aplastic anemia","Appendicitis","Atony of colon","Autonomic dysreflexia","Benign prostatic hyperplasia","Bladder outflow obstruction","Bleeding","Brain damage","Breastfeeding (mother)","Bronchitis","Cerebral ischemia","Chronic heart failure","Chronic lung disease","Chronic myocardial ischemia","Chronic obstructive lung disease","Complete trisomy 21 syndrome","Conduction disorder of the heart","Continuous fever","Cor pulmonale","Cystic fibrosis","Dehydration","Depressive disorder","Dermatitis herpetiformis","Diabetes mellitus","Diarrhea","Disease of liver","Disorder of autonomic nervous system","Disorder of cardiovascular system","Disorder of coronary artery","Disorder of thyroid gland","Disturbance of salivary secretion","Drowsy","Drug AND/OR toxin-induced diarrhea","Dyspnea","Ergot Alkaloid Toxicity","Factor II deficiency","Fever greater than 100.4 Fahrenheit","Fibrosis of lung","Fibrosis of pleura","Gastric ulcer","Gastritis","Gastroesophageal reflux disease","Gastrointestinal hemorrhage","Gastrointestinal obstruction","Gastrointestinal ulcer","Glaucoma","Goiter","Gout","Granulocytopenic disorder","HLA-B 1502 Positive Status","Hashimoto thyroiditis","Heart disease","Hemophilia","Hepatic coma","Hepatic encephalopathy","Hepatic failure","Hiatal hernia","Hyperactive behavior","Hyperammonemia","Hypercalcemia","Hyperglycemia","Hyperkalemia","Hyperparathyroidism","Hyperplasia of gingiva","Hypertensive disorder","Hyperthyroidism","Hypocomplementemic urticarial vasculitis","Hypothyroidism","Hypovolemic shock","Impaired renal function disorder","Incontinence of feces","Insomnia","Kidney disease","Kidney stone","Leukopenia","Low blood pressure","Lymphadenopathy","Megaloblastic anemia","Multiple organ failure","Myasthenia gravis","Myocardial dysfunction","Myocardial infarction","Myocardial infarction in recovery phase","Myocardial ischemia","Nasal polyp","Necrotizing enterocolitis in fetus OR newborn","Neutropenic disorder","Non-infective meningitis","Obsessive-compulsive disorder","Osteolysis","Osteomalacia","Osteopenia","Pancytopenia","Panic disorder","Paralytic ileus","Peptic reflux disease","Peptic ulcer","Peripheral ischemia","Peripheral vascular disease","Poisoning by acetaminophen","Poisoning by phenobarbital","Porphyria","Pregnancy, function","Psychotic disorder","Pulmonary edema","Pyloric obstruction","Raynaud's phenomenon","Respiratory insufficiency","Retention of urine","Retroperitoneal fibrosis","Reye's syndrome","Sarcoidosis","Sepsis syndrome","Severe Hypoxemia","Severe Pruritus","Severe chronic ulcerative colitis","Shock","Sleep apnea","Sleep automatism","Smokes tobacco daily","Smoking cessation assistance","Spastic paralysis","Substance abuse","Suicidal thoughts","Systemic lupus erythematosus","Tachyarrhythmia","Theophylline Toxicity","Third trimester pregnancy","Thrombocytopenic disorder","Thrombophlebitis","Thrombotic thrombocytopenic purpura","Toxic megacolon","Ulcerative colitis","Urinary tract obstruction","Vitamin K deficiency","von Willebrand disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL40","moleculeType":"Small molecule","molecularWeight":"232.24"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 1 group I member 3, GABA-A receptor alpha-1/beta-2/gamma-2"},"_scrapedAt":"2026-03-28T06:42:06.405Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Bipolar disorder in remission","diseaseId":"bipolar-disorder-in-remission","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Cluster Headache Prevention","diseaseId":"cluster-headache-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Cluster headache syndrome","diseaseId":"cluster-headache-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Epilepsy","diseaseId":"epilepsy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Epilepsy characterized by intractable complex partial seizures","diseaseId":"epilepsy-characterized-by-intractable-complex-partial-seizures","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Lennox-Gastaut syndrome","diseaseId":"lennox-gastaut-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Migraine","diseaseId":"migraine","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Simple partial seizure","diseaseId":"simple-partial-seizure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Tonic-clonic epilepsy","diseaseId":"tonic-clonic-epilepsy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Tonic-clonic seizure","diseaseId":"tonic-clonic-seizure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vascular headache","diseaseId":"vascular-headache","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07401433","phase":"NA","title":"Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.","status":"COMPLETED","sponsor":"Hayat Abad Medical Complex, Peshawar","startDate":"2024-04-08","conditions":"Neonatal Seizures","enrollment":260},{"nctId":"NCT07284498","phase":"PHASE4","title":"Treatment of Seizures in Neonate With HIE","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-01-01","conditions":"Neonatal Seizures, HIE - Hypoxic - Ischemic Encephalopathy","enrollment":66},{"nctId":"NCT07274410","phase":"","title":"Clinical Profile And Outcomes Of Neonatal Convulsions In The Neonatal Intensive Care Unit At Assiut University Children's Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":"Neonatal Convulsions, Newborn Seizure Disorders, Seizures","enrollment":139},{"nctId":"NCT03368664","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT","status":"TERMINATED","sponsor":"Genzyme, a Sanofi Company","startDate":"2017-10-24","conditions":"Multiple Sclerosis","enrollment":16},{"nctId":"NCT03196466","phase":"","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-19","conditions":"Epilepsy","enrollment":753},{"nctId":"NCT06081283","phase":"PHASE4","title":"Antiseizure Medication in Seizure Networks at Early Acute Brain Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-11-20","conditions":"Brain Injuries, Acute, Brain Injuries, Traumatic, Brain Ischemia","enrollment":5},{"nctId":"NCT05610085","phase":"PHASE2","title":"A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2023-03-24","conditions":"Neonatal Seizure, Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy","enrollment":133},{"nctId":"NCT07098728","phase":"NA","title":"Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures","status":"RECRUITING","sponsor":"Ministry of Health and Sports, Myanmar","startDate":"2025-07-22","conditions":"Seizure","enrollment":180},{"nctId":"NCT03325439","phase":"PHASE3","title":"A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures","status":"TERMINATED","sponsor":"UCB Biopharma SRL","startDate":"2019-05-07","conditions":"Electroencephalographic Neonatal Seizures","enrollment":9},{"nctId":"NCT02421068","phase":"","title":"Population PK/PD of Off Label Drugs in Premature Neonates","status":"COMPLETED","sponsor":"Sinno H.P. Simons","startDate":"2014-08","conditions":"Premature Birth","enrollment":246},{"nctId":"NCT02550028","phase":"PHASE1, PHASE2","title":"Levetiracetam Treatment of Neonatal Seizures","status":"TERMINATED","sponsor":"Children's Hospital of Fudan University","startDate":"2015-09-01","conditions":"Neonatal Seizures","enrollment":60},{"nctId":"NCT06181383","phase":"","title":"Phenobarbital Versus Levetiracetam Neonatal Convulsion","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-12-30","conditions":"Neonatal Convulsion","enrollment":42},{"nctId":"NCT03586089","phase":"NA","title":"Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome","status":"TERMINATED","sponsor":"Unity Health Toronto","startDate":"2021-06-11","conditions":"Alcohol Withdrawal Delirium, Alcohol Withdrawal, Alcohol Withdrawal Seizures","enrollment":8},{"nctId":"NCT04320940","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures","status":"TERMINATED","sponsor":"NEMA Research, Inc.","startDate":"2021-03-12","conditions":"Epilepsy, Benign Neonatal","enrollment":4},{"nctId":"NCT04692844","phase":"","title":"Pathophysiology of Tremor-modulating Mechanisms of Propranolol and Primidone in Essential Tremor","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2017-08-28","conditions":"Essential Tremor","enrollment":61},{"nctId":"NCT05346666","phase":"PHASE3","title":"Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.","status":"UNKNOWN","sponsor":"Damanhour University","startDate":"2022-06-25","conditions":"Epilepsy","enrollment":50},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT05291455","phase":"PHASE3","title":"Lacosamide in Neonatal Status Epilepticus","status":"UNKNOWN","sponsor":"Sherief Abd-Elsalam","startDate":"2022-03-01","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT05236166","phase":"NA","title":"Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2017-04-26","conditions":"Epilepsy","enrollment":48},{"nctId":"NCT03670160","phase":"PHASE2","title":"Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of Tennessee Medical Center","startDate":"2018-10-01","conditions":"Neonatal Abstinence Syndrome","enrollment":25},{"nctId":"NCT03632915","phase":"","title":"Pharmacokinetics of Antiepileptics in Patients on CRRT","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2017-11-20","conditions":"Acute Kidney Injury, Renal Insufficiency, Renal Failure","enrollment":18},{"nctId":"NCT00830531","phase":"PHASE1","title":"Pilot Study of Bumetanide for Newborn Seizures","status":"COMPLETED","sponsor":"Soul, Janet , M.D.","startDate":"2010-01","conditions":"Seizures","enrollment":43},{"nctId":"NCT02789176","phase":"","title":"Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2016-10","conditions":"Neonatal Seizures","enrollment":303},{"nctId":"NCT04156464","phase":"PHASE4","title":"Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit","status":"UNKNOWN","sponsor":"OSF Healthcare System","startDate":"2020-07-06","conditions":"Alcohol Withdrawal, Alcohol Withdrawal Delirium","enrollment":142},{"nctId":"NCT02810782","phase":"PHASE3","title":"How to Treat Opiate Withdrawal in Neonates","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2001-06","conditions":"Neonatal Abstinence Syndrome","enrollment":120},{"nctId":"NCT00185692","phase":"PHASE2","title":"Allogeneic Transplantation From Related Haploidentical Donors","status":"COMPLETED","sponsor":"Stanford University","startDate":"2000-08","conditions":"Blood Cancer, Leukemia, Graft Versus Host Disease","enrollment":16},{"nctId":"NCT01958476","phase":"PHASE3","title":"Improving Outcomes in Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-09","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal","enrollment":117},{"nctId":"NCT03788889","phase":"PHASE4","title":"Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine","status":"WITHDRAWN","sponsor":"Santa Barbara Cottage Hospital","startDate":"2019-04-12","conditions":"Alcohol Withdrawal Syndrome","enrollment":""},{"nctId":"NCT03602118","phase":"PHASE3","title":"Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures","status":"WITHDRAWN","sponsor":"PharPoint Research, Inc.","startDate":"2019-11","conditions":"Neonatal Seizure","enrollment":""},{"nctId":"NCT01720667","phase":"PHASE1, PHASE2","title":"Efficacy of Intravenous Levetiracetam in Neonatal Seizures","status":"COMPLETED","sponsor":"Richard H. Haas","startDate":"2013-03","conditions":"Neonatal Seizures","enrollment":280},{"nctId":"NCT03025906","phase":"PHASE2","title":"Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2017-02-16","conditions":"Generalized Convulsive Status Epilepticus","enrollment":120},{"nctId":"NCT00009620","phase":"PHASE3","title":"Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"1993-02","conditions":"Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age","enrollment":610},{"nctId":"NCT00404248","phase":"PHASE1, PHASE2","title":"Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2007-01","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT01713946","phase":"PHASE3","title":"A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-04-29","conditions":"Tuberous Sclerosis Complex-associated Refractory Seizures","enrollment":366},{"nctId":"NCT03650270","phase":"PHASE3","title":"Childhood Convulsive Status Epilepticus Management In A Resource Limited Setting","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2015-03-01","conditions":"Pediatric Status Epilepticus","enrollment":198},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT01284556","phase":"PHASE3","title":"Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures","status":"COMPLETED","sponsor":"West-Ward Pharmaceutical","startDate":"2010-11","conditions":"Epilepsy","enrollment":314},{"nctId":"NCT02727101","phase":"PHASE4","title":"Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.","status":"TERMINATED","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2015-11","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT02726867","phase":"PHASE3","title":"Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus","status":"WITHDRAWN","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2014-02","conditions":"Epilepsy, Status Epilepticus","enrollment":""},{"nctId":"NCT00314340","phase":"PHASE4","title":"A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2005-11","conditions":"Chronic Pain","enrollment":12},{"nctId":"NCT03107507","phase":"PHASE4","title":"Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2017-03-25","conditions":"Neonatal Seizures","enrollment":40},{"nctId":"NCT02191358","phase":"","title":"YouScript IMPACT Registry","status":"COMPLETED","sponsor":"Genelex Corporation","startDate":"2014-10","conditions":"Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation","enrollment":800},{"nctId":"NCT02008123","phase":"PHASE2","title":"Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant","status":"WITHDRAWN","sponsor":"Dent Neuroscience Research Center","startDate":"2013-08","conditions":"Clopidogrel Resistance, Secondary Stroke Prevention","enrollment":""},{"nctId":"NCT01982812","phase":"PHASE2","title":"A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2014-01","conditions":"Seizure, Epilepsy, Cerebral Malaria","enrollment":44},{"nctId":"NCT01089504","phase":"PHASE4","title":"Prophylactic Phenobarbital After Neonatal Seizures","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2010-09","conditions":"Neonatal Seizures","enrollment":13},{"nctId":"NCT01027715","phase":"NA","title":"The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2010-01","conditions":"Seizures, Encephalopathy","enrollment":69},{"nctId":"NCT01434225","phase":"PHASE1, PHASE2","title":"NEMO1:NEonatal Seizure Using Medication Off-patent","status":"COMPLETED","sponsor":"Great Ormond Street Hospital for Children NHS Foundation Trust","startDate":"2011-08","conditions":"Neonatal Seizures","enrollment":14},{"nctId":"NCT00068770","phase":"PHASE2","title":"Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2003-10","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT00530413","phase":"NA","title":"Study of Phenobarbital Inhibition of Catamenial Epilepsy","status":"WITHDRAWN","sponsor":"University of Toledo Health Science Campus","startDate":"2007-03","conditions":"Epilepsy","enrollment":""},{"nctId":"NCT01175668","phase":"NA","title":"Clonidine for Neonatal Abstinence Syndrome Study","status":"TERMINATED","sponsor":"Baystate Medical Center","startDate":"2010-07","conditions":"Neonatal Abstinence Syndrome","enrollment":68},{"nctId":"NCT01723722","phase":"PHASE4","title":"Treatment of Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Eastern Maine Medical Center","startDate":"2007-01","conditions":"Neonatal Abstinence Syndrome","enrollment":40},{"nctId":"NCT00610571","phase":"PHASE1","title":"Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas","status":"COMPLETED","sponsor":"Katy Peters","startDate":"2004-04","conditions":"Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma","enrollment":62},{"nctId":"NCT00612638","phase":"PHASE1","title":"Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas","status":"COMPLETED","sponsor":"Duke University","startDate":"2005-01","conditions":"Glioblastoma, Gliosarcoma","enrollment":96},{"nctId":"NCT01475656","phase":"","title":"Efficacy of Keppra for Neonatal Seizures","status":"TERMINATED","sponsor":"Stephanie Merhar, MD","startDate":"2011-11","conditions":"Neonatal Seizures","enrollment":2},{"nctId":"NCT00612651","phase":"PHASE1","title":"PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas","status":"COMPLETED","sponsor":"Duke University","startDate":"2005-10","conditions":"Gliosarcoma, Glioblastoma, Anaplastic Astrocytoma","enrollment":37},{"nctId":"NCT00002759","phase":"PHASE1","title":"Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1996-06","conditions":"Drug/Agent Toxicity by Tissue/Organ, Lymphoma, Neutropenia","enrollment":3},{"nctId":"NCT00734864","phase":"PHASE1","title":"Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma","status":"WITHDRAWN","sponsor":"Annick Desjardins","startDate":"2009-06","conditions":"Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma","enrollment":""},{"nctId":"NCT01390909","phase":"","title":"Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-05","conditions":"Epilepsy","enrollment":12386},{"nctId":"NCT01184417","phase":"NA","title":"Phenobarbital for Acute Alcohol Withdrawal","status":"COMPLETED","sponsor":"Jonathan Rosenson","startDate":"2009-01","conditions":"Alcohol Withdrawal","enrollment":102},{"nctId":"NCT01224457","phase":"NA","title":"Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2008-05","conditions":"Neonatal Seizure","enrollment":52},{"nctId":"NCT01132040","phase":"PHASE1","title":"Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-08","conditions":"Healthy","enrollment":24},{"nctId":"NCT00685165","phase":"PHASE1","title":"Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2004-05","conditions":"Therapeutic Equivalency","enrollment":22},{"nctId":"NCT00552526","phase":"PHASE4","title":"Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2007-11","conditions":"Epilepsy, Mental Retardation","enrollment":60},{"nctId":"NCT00381537","phase":"NA","title":"Prediction of Childhood Epilepsy Outcome in Bangladesh","status":"COMPLETED","sponsor":"Institute of Child Health","startDate":"","conditions":"Epilepsy","enrollment":92}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"phenobarbitone","genericName":"phenobarbitone","companyName":"Institute of Child Health","companyId":"institute-of-child-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Phenobarbitone, also known as phenobarbital, is a medication of the barbiturate type used to treat certain types of epilepsy, including in young children. It is also recommended by the World Health Organization for the treatment of epilepsy in developing countries.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}